Covered recipient · General Payments record
JESSE W HEARD
Allopathic & Osteopathic Physicians Family Medicine
General Payments · PY2018–2024
$1,787.53
- Reported across 111 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $475.27 | 26 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| ABBVIE INC. | $273.78 | 15 |
| GlaxoSmithKline, LLC. | $49.91 | 3 |
| Exact Sciences Corporation | $44.62 | 2 |
| Acerta Pharma LLC | $40.82 | 2 |
| Astellas Pharma US Inc | $36.89 | 2 |
| Novo Nordisk AS | $16.04 | 1 |
| Axsome Therapeutics, Inc. | $13.21 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (26)
Sorted by paying entity, then date · as published by CMS
Program year 2024 201820192020202120222023
Record-level detail is published for PY2024; earlier years are summarised in
“By program year”.
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| ABBVIE INC. | $23.21 | 01/09/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103897386 | CMS |
| ABBVIE INC. | $22.45 | 01/11/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103897388 | CMS |
| ABBVIE INC. | $8.92 | 01/25/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103897390 | CMS |
| ABBVIE INC. | $6.66 | 02/29/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103897392 | CMS |
| ABBVIE INC. | $19.99 | 03/05/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103897394 | CMS |
| ABBVIE INC. | $28.74 | 04/05/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103897396 | CMS |
| ABBVIE INC. | $19.11 | 05/07/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103897398 | CMS |
| ABBVIE INC. | $25.58 | 06/12/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103897400 | CMS |
| ABBVIE INC. | $8.12 | 06/24/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103897402 | CMS |
| ABBVIE INC. | $23.77 | 07/01/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103897404 | CMS |
| ABBVIE INC. | $23.89 | 07/11/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103897406 | CMS |
| ABBVIE INC. | $25.76 | 07/19/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103897408 | CMS |
| ABBVIE INC. | $1.88 | 07/30/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103897410 | CMS |
| ABBVIE INC. | $23.77 | 08/29/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103897412 | CMS |
| ABBVIE INC. | $11.93 | 12/06/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103897414 | CMS |
| Astellas Pharma US Inc | $14.52 | 04/16/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1139332844 | CMS |
| Astellas Pharma US Inc | $22.37 | 10/29/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1139417775 | CMS |
| AstraZeneca Pharmaceuticals LP | $18.44 | 03/26/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104273149 | CMS |
| AstraZeneca Pharmaceuticals LP | $22.38 | 04/30/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105374939 | CMS |
| Axsome Therapeutics, Inc. | $13.21 | 01/02/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1148290389 | CMS |
| Exact Sciences Corporation | $22.55 | 03/20/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1114697187 | CMS |
| Exact Sciences Corporation | $22.07 | 11/12/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1114697193 | CMS |
| GlaxoSmithKline, LLC. | $14.45 | 03/04/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1116416870 | CMS |
| GlaxoSmithKline, LLC. | $19.75 | 04/02/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1116708447 | CMS |
| GlaxoSmithKline, LLC. | $15.71 | 05/01/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1116700351 | CMS |
| Novo Nordisk Inc | $16.04 | 02/06/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1096609802 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2018, 2019, 2020, 2021, 2022, 2023, 2024
- Source files
- Dataset page · Bulk file · PY2018 , PY2019 , PY2020 , PY2021 , PY2022 , PY2023 , PY2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.